Aaron Kantoff insider trades

Open-market stock purchases and sales by Aaron Kantoff, Unknown at Avalo Therapeutics, Inc, from SEC Form 4 filings since Nov 18, 2021.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +231%.

Recent trades

DateStockTradeValue
Jun 2, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Mar 28, 2026AVTX Avalo Therapeutics, IncBought (not open market)—
Oct 28, 2025TRML Tourmaline Bio, IncSold (not open market)—
Oct 28, 2025TRML Tourmaline Bio, IncSold (not open market)$139K
Oct 28, 2025TRML Tourmaline Bio, IncSold (not open market)$315K
Oct 24, 2025TRML Tourmaline Bio, IncSold (not open market)—

Companies traded

  • AVTX Avalo Therapeutics, Inc: other filings, last Jun 2, 2026
  • TRML Tourmaline Bio, Inc: 1 buy, last Oct 28, 2025
  • CNTA Centessa Pharmaceuticals plc: 1 buy, last Nov 18, 2021

Get free alerts when Aaron Kantoff files a new trade →